Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances

Acta Pharmacologica Sinica

Volumn 23, Issue 5, 2002, Pages 412-422

  Sikiric, Predrag ^a   Jelovac, Nikola ^a   Jelovac Gjeldum, Andjelka ^a   Dodig, Goran ^a   Staresinic, Mario ^a   Anic, Tomislav ^a   Zoricic, Ivan ^a   Rak, Davor ^a   Perovic, Darko ^a   Aralica, Gorana ^a   Buljat, Gojko ^a   Prkacin, Ingrid ^a   Lovric Bencic, Martina ^a   Separovic, Jadranka ^a   Seiwerth, Sven ^a   Rucman, Rudolf ^a   Petek, Marijan ^a   Turkovic, Branko ^a   Ziger, Tihomil ^a   Boban Blagaic, Alenka ^a   Bedekovic, Vlado ^a   Tonkic, Ante ^a   Babic, Slaven ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Amphetamine; BPC 157; Stereotyped behavior

Indexed keywords

AMPHETAMINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR STIMULATING AGENT; PEPTIDE FRAGMENT; PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG POTENTIATION; MALE; NONHUMAN; RAT; STARTLE REFLEX; STEREOTYPY; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; RANDOMIZATION; TIME; WISTAR RAT;

AMPHETAMINE; ANIMALS; DOPAMINE AGENTS; DRUG INTERACTIONS; MALE; PEPTIDE FRAGMENTS; PROTEINS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STARTLE REACTION; STEREOTYPED BEHAVIOR; TIME FACTORS;

EID: 0036251985     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Neuroendocrine mechanisms of stress ulceration: Focus on thyrotropin releasing hormone (TRH)
2. Possible involvement of a noradrenergic area of the amygdala with stereotyped behaviour
3. 2 dopamine receptor-mediated mechanisms and behavioral supersensitivity
4. Amantadine
5. Characteristics of "reverse tolerance" to amphetamine-induced locomotor stimulation in mice
6. Possible role of p-hydroxynorephedrine in the depletion of norepinephrine induced by d-amphetamine and in tolerance to this drug
7. Increased effects of repetitive cocaine administration in the rat
8. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration
9. Time course of the development of the enhaced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine
10. A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine
11. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: The effect on catalepsy and gastric ulcers
12. A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
13. The anti-depressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants
14. The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam
15. The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice
16. Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anti-convulsant spectra
17. Anxiolytic effect of BPC-157, a gastric pentadecapeptide: Shock probe/burying test and light/dark test
18. The pharmacological properties of the novel peptide BPC 157 (PL-10)
19. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cunetidine and misoprostol in mice
20. New model of cytoprotection/adaptive cytoprotection in rats: Endogenous small irritants, antiulcer agents and indomethacin
21. Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress
22. G-nitro-L-arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure
23. The beneficial effect of a novel pentadecapepride BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity
24. Pentadecapeptide BPC 157 beneficially influences the healing of colon-colon anastomoses in rats
25. Osteogenic effect of a gastric pentadecapeptide BPC 157, on the healing of segmental bone defect in rabbits. A comparison with bone marrow and autologous cortical bone implantation
26. Effects of BPC 157 on the healing of comeal lesions
27. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats
28. Pentadecapeptide BPC 157 cream improves bum-wound healing and attenuates burn-gastric lesions in mice
29. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats
30. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury
31. The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis in rats
32. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats
33. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure
34. Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice
35. Dopamine antagonists induce gastric lesions in rats